Skip to Content

Health

FDA says Johnson & Johnson Covid-19 vaccine meets requirements for emergency use authorization

In an analysis released Wednesday, the US Food and Drug Administration said the Johnson & Johnson Covid-19 vaccine has met the requirements for emergency use authorization. The efficacy of the Johnson & Johnson vaccine against moderate to severe/critical Covid-19 across all geographic areas was 66.9% at least 14 days after the single dose vaccination and

Continue Reading

Experts worry variant-fueled surge of Covid-19 could be weeks away but cases will likely fall again by summer

Coronavirus infections across the US are still on the way down, and more Americans are getting vaccinated — but variants could cause complications soon. Several experts predicted Tuesday the highly contagious B.1.1.7 variant first detected in the UK is likely to fuel another surge of cases in just a matter of weeks. “It could result

Continue Reading

FDA advisers to consider recommending single-dose Johnson & Johnson Covid-19 vaccine this week

Vaccine advisers to the US Food and Drug Administration will meet Friday to discuss whether to recommend Johnson & Johnson’s Covid-19 vaccine for emergency use authorization. The vaccine is the third under consideration for the US market, and would be the first single-dose Covid-19 shot available here. Like the earlier Covid-19 vaccines, it was developed

Continue Reading

Educators may be more central drivers of Covid-19 in schools than students, CDC study finds

A study that found teachers — not students — were the probable source of several school-related Covid-19 outbreaks highlights the need to maintain mask and distancing guidelines and to prioritize teachers and school staff for vaccination, US Centers for Disease Control and Prevention Director Dr. Rochelle Walensky said Monday. The “concerning report,” published Monday, details

Continue Reading

FDA advisers to consider EUA recommendation for single-dose Johnson & Johnson Covid-19 vaccine this week

Vaccine advisers to the US Food and Drug Administration will meet Friday to discuss whether to recommend Johnson & Johnson’s Covid-19 vaccine for emergency use authorization. The vaccine is the third under consideration for the US market, and would be the first single-dose Covid-19 shot available here. Like the earlier Covid-19 vaccines, it was developed

Continue Reading